Gujrathi Sheila
Director at VTYX; Chief Medical Officer at Receptos, Inc.
- Sold, on record
- $8.5M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Mar 30, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- VTYXVentyx Biosciences, Inc.Director
- Receptos, Inc.Chief Medical Officer
Sales by reason
0
Routine
2
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- VTYX100,000 shares
- Receptos, Inc.60,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Receptos, Inc.Plan not statedSep 22, 2014 2014
Sold 30,000 shares at $61.45 ($1.8M)
Gujrathi Sheila, Chief Medical Officer
Sold 16.6% of holdings ($11.1M position)150,661 shares leftFirst sale on recordFiling
- 2 Form 4 sale Receptos, Inc.Plan not statedNov 11, 2014 +50 days
Sold 30,000 shares at $108.99 ($3.3M)
Gujrathi Sheila, Chief Medical Officer
Sold 19.9% of holdings ($16.4M position)120,661 shares leftFiling
- 3 Form 4 sale VTYXUnusualMar 30, 2023 +3061 days
Sold 100,000 shares at $33.73 ($3.4M)
Gujrathi Sheila, Director
No 10b5-1 planSold 100% of holdings ($3.4M position)0 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 | Mar 31, 2023 | VTYX | Director | Form 4 sale | 100,000 | $3.4M | 100.0% | Unusual | SEC |
| Nov 11, 2014 | Nov 12, 2014 | Receptos, Inc. | Chief Medical Officer | Form 4 sale | 30,000 | $3.3M | 19.9% | Plan not stated | SEC |
| Sep 22, 2014 | Sep 24, 2014 | Receptos, Inc. | Chief Medical Officer | Form 4 sale | 30,000 | $1.8M | 16.6% | Plan not stated | SEC |